Home » Authors » Karl Thiel

Articles by Karl Thiel

The Best and Worst of Biotech in 2008

Jan. 5, 2009

New Washington Alignments Bring Period of Uncertainty

Dec. 1, 2008

How Biotech Can Make Even Cash Look Bad

Nov. 3, 2008

Has the Economic Mess Diluted Biotech's Hand?

Sep. 29, 2008

Good News from Capital Markets: Some VCs Taking a Long View

Sep. 2, 2008

Are Biotechs Build to Prosper or Are They Built to be Sold?

Aug. 4, 2008

Two-Year DTC Ad Moratorium Weakens Patient Education Role

June 30, 2008

Election 2008: Say Hail to the Chief of Scientific Illiteracy

June 2, 2008

Japan Pharmas' Love for U.S. Biotechs Just Heating Up

April 28, 2008

The FDA is Treading Water Until a True Leader Arrives

March 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...